InsiderClue
← All stocks

Entrada Therapeutics, Inc.

TRDA Net selling
CIK 0001689375 #3614 in the set updated 17 Sep 2026
Bought (12 mo)
$1.64M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$15.10M
$1.03M on a plan · $229.95K straight out of an exercise
Sold at will
$13.85M
35 of 44 sales
Net
−$13.46M
−$12.20M against sales at will

By person

10 insiders · 61 transactions
5.8×

Dipal Doshi holds 5.8 times base salary in stock. $3.69M of shares against $635.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dipal Doshi last reported holding, valued at $7.13, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PARMAR KUSH
Director
—
$3.65M (6)
−$3.65M
2,691,337
6.91%
$19.19M
−18.8%
MPM BioVentures 2014, L.P.
10% owner
—
$3.60M (12)
−$3.60M
8,203,463
21.07%
$58.49M
−6.2%
MPM BIOVENTURES 2018, L.P.
10% owner
—
$3.60M (12)
−$3.60M
8,203,463
21.07%
$58.49M
−6.2%
5AM Ventures V, L.P. entity
10% owner
—
$3.00M (5)
−$3.00M
3,877,094
9.96%
$27.64M
−12.1%
BAKER BROS. ADVISORS LP entity
10% owner
$1.61M (16)
—
+$1.61M
4,691,392
12.05%
$33.45M
+4.6%
WENTWORTH KORY JAMES
Chief Financial Officer
—
$433.58K (5) scheduled
−$433.58K
117,277
0.3012%
$836.19K
+53.3%
Dowden Nathan J
President & COO
—
$425.72K (3) scheduled
−$425.72K
196,060
0.5035%
$1.40M
+55.6%
Sethuraman Natarajan
President, Research & Develop.
—
$398.81K (1) scheduled
−$398.81K
214,238
0.5502%
$1.53M
+16.6%
Zeiher Bernhardt G
Director
$29.32K (1)
—
+$29.32K
5,000
0.0128%
$35.65K
—
Doshi Dipal
CEO
—
—
—
517,290
1.33%
$3.69M
+58.8%

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
Zeiher Bernhardt G
20 May 2026
Director
Buy indirect
5,000
$5.86
$29.32K
BAKER BROS. ADVISORS LP
20 Nov 2025
10% owner
Buy indirect
13,082
$9.07
$118.69K
BAKER BROS. ADVISORS LP
20 Nov 2025
10% owner
Buy indirect
1,186
$9.07
$10.76K
BAKER BROS. ADVISORS LP
20 Nov 2025
10% owner
Buy indirect
13,386
$9.07
$121.39K
BAKER BROS. ADVISORS LP
20 Nov 2025
10% owner
Buy indirect
1,213
$9.07
$11.00K
BAKER BROS. ADVISORS LP
12 Nov 2025
10% owner
Buy indirect
11,494
$7.95
$91.43K
BAKER BROS. ADVISORS LP
12 Nov 2025
10% owner
Buy indirect
1,040
$7.95
$8.27K
BAKER BROS. ADVISORS LP
12 Nov 2025
10% owner
Buy indirect
80,881
$7.73
$625.33K
BAKER BROS. ADVISORS LP
12 Nov 2025
10% owner
Buy indirect
7,321
$7.73
$56.60K
BAKER BROS. ADVISORS LP
11 Nov 2025
10% owner
Buy indirect
30,879
$7.54
$232.81K
BAKER BROS. ADVISORS LP
11 Nov 2025
10% owner
Buy indirect
2,795
$7.54
$21.07K
BAKER BROS. ADVISORS LP
11 Nov 2025
10% owner
Buy indirect
11,701
$7.39
$86.48K
BAKER BROS. ADVISORS LP
11 Nov 2025
10% owner
Buy indirect
1,059
$7.39
$7.83K
BAKER BROS. ADVISORS LP
10 Nov 2025
10% owner
Buy indirect
2,947
$7.22
$21.29K
BAKER BROS. ADVISORS LP
10 Nov 2025
10% owner
Buy indirect
267
$7.22
$1.93K
BAKER BROS. ADVISORS LP
10 Nov 2025
10% owner
Buy indirect
25,364
$7.21
$182.97K
BAKER BROS. ADVISORS LP
10 Nov 2025
10% owner
Buy indirect
2,296
$7.21
$16.56K
Show all 61 transactions →

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 1
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 396,101
History held since 1 Nov 2021